Long-term Effect of Dual Antiplatelet Treatment after Coronary Artery Bypass Grafting in Diabetic Patients

Diabetic patients have an increased incidence of late major adverse cardiovascular events (MACE) after coronary artery bypass surgery (CABG), and platelet aggregation is related to the appearance of MACE. We analysed the effect of dual antiplatelet treatment (DAT), compared to single antiplatelet treatment (SAT), over late outcomes after CABG in a diabetic population. This is a retrospective study that included all diabetic patients discharged after CABG, during the years 2009 and 2010, with a two years clinical follow-up. Patients were classified in two groups, depending on the administered antiplatelet treatment. The primary end-point was the composite of acute coronary syndrome, unplanned revascularization, stroke and cardiovascular death.